The Global Leukodystrophy Initiative is an international consortium that aims to accelerate the discovery of novel genetic variations responsible for paediatric white matter disorders and to translate these findings into clinical treatments using gene and stem cell therapies.
Company Details
- Employees
- 3
- Founded
- 2013
- Address
- 3615 Civic Center Blvd, Philadelphia,pennsylvania 19104,united States
- Industry
- Philanthropic Fundraising Services
- NAICS
-
Grantmaking and Giving ServicesGrantmaking FoundationsVoluntary Health OrganizationsOther Grantmaking and Giving Services
- Website
- http://www.theglia.org
- Keywords
- Philadelphia.
- HQ
- Philadelphia, Pennsylvania
- Competitors
- Katalytic, Pinnacle Solutions (Serving Science Better), National Institute of Neurological Disorders and Stroke (NINDS), Cure LBSL, Patient Advocate Certification Board, Inc. (PACB), Children's Hospital of Philadelphia, Baby Ducks in a Row, World Leukodystrophy Alliance, The PMD Foundation, Rare Diseases Clinical Research Network (RDCRN).
Global Leukodystrophy Initiative Questions
Global Leukodystrophy Initiative's website is http://www.theglia.org
Global Leukodystrophy Initiative's LinkedIn profile is https://www.linkedin.com/company/wearetheglia
Global Leukodystrophy Initiative has
3 employees.
View email and phone details for 3
employees at Global Leukodystrophy Initiative.
Global Leukodystrophy Initiative's industry is
Philanthropic Fundraising Services
Global Leukodystrophy Initiative's top competitors are
Katalytic,
Pinnacle Solutions (Serving Science Better),
National Institute Of Neurological Disorders And Stroke (Ninds),
Cure Lbsl,
Patient Advocate Certification Board, Inc. (Pacb),
Children's Hospital Of Philadelphia,
Baby Ducks In A Row,
World Leukodystrophy Alliance,
The Pmd Foundation,
Rare Diseases Clinical Research Network (Rdcrn).
Global Leukodystrophy Initiative's categories are Philanthropic Fundraising Services
Global Leukodystrophy Initiative's founding year is 2013
